Iroko is a global specialty pharmaceutical company dedicated to advancing the science of responsible pain management. Using innovative technology, Iroko is developing new drug products based on existing NSAIDs.

Established in 2007, Iroko has assembled a workforce led by a seasoned management team, acquired several prescription pharmaceuticals, established sales and distribution networks in more than 50 countries, and created a robust portfolio of NSAID development programs. Our operating headquarters is located in Philadelphia’s historic Navy Yard.

At Iroko, we are committed to providing treatment options for responsible pain management. Our robust product pipeline consists of low-dose NSAIDs created using innovative proprietary SoluMatrix Fine Particle Technology. These drug products are designed to offer pain relief at low doses.

Discover an innovative way to feel better

Iroko: An Innovator in Pain Management Iroko Cares About Community

SoluMatrix Fine Particle Technology™ is a trademark of iCeutica Inc., and is licensed to Iroko for exclusive use in NSAIDs.

Who We Are